Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Bispecific Antibodies, Lymphoma

Nancy Bartlett

MD

🏢Washington University School of Medicine🌐USA

Professor of Medicine, Koman Chair in Medical Oncology

75
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Nancy Bartlett is a lymphoma clinical trialist at Washington University who led pivotal mosunetuzumab trials in relapsed follicular lymphoma. She has contributed to bispecific antibody development across lymphoma subtypes. Her work established mosunetuzumab as standard of care in relapsed FL.

Share:

🧪Research Fields 研究领域

mosunetuzumab
follicular lymphoma
bispecific antibodies
DLBCL
indolent lymphoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Nancy Bartlett 的研究动态

Follow Nancy Bartlett's research updates

留下邮箱,当我们发布与 Nancy Bartlett(Washington University School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment